DMAA
Financial ServicesDrugs Made In America Acquisition Corp.
$10.37
$-0.01 (-0.10%)
Jan 5, 2026
Price History (1Y)
Analysis
Drugs Made In America Acquisition Corp. is a shell company within the Financial Services sector and Shell Companies industry. Its market capitalization stands at $347.57M. The company's financial health is marked by negligible profitability, with gross margin, operating margin, and profit margin all registering 0.0%. However, its net income over the trailing twelve months amounts to $5.45M. The balance sheet shows a cash position of $717, while debt information is not available. The current ratio stands at 0.06. The company's valuation context does not include P/E or forward P/E ratios due to lack of data. It also lacks revenue and EBITDA figures for comparison purposes.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Visit website →Key Statistics
- Market Cap
- $347.57M
- P/E Ratio
- N/A
- 52-Week High
- $10.39
- 52-Week Low
- $9.95
- Avg Volume
- 22.69K
Company Info
- Industry
- Shell Companies
- Exchange
- NGM
- Country
- United States